ARCHIVES

First NCI Director To Resign Due To Presidential Election?

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

January 12, 1979

NCCS Networker Volume 1 Issue 3, Fall 1987

September 13, 1987

FDA Committee IK IL-2/LAK For Modified Group C

May 1, 1987

DCT Program Cutbacks Planned as Research Stressed In 4 Cancers

February 26, 1993

Two Phase III Trials Show Increase In PFS In Two Distinct Patient Populations

June 28, 2013

Kessler Says FDA Working To Expedite Secondary Approvals

January 31, 1992